Immediate Impact

1 hit

Citing Papers

Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial
2023 Hit

Works of Francesco Menegale being referenced

Evaluation of Waning of SARS-CoV-2 Vaccine–Induced Immunity
2023 Hit
Rankless by CCL
2026